Our results suggested that suppression of REDD1 and AKT in response to glutamine deprivation enhances cell sensitivity to IR, and the targeting of REDD1 and AKT under glutamine deprivation conditions may be an effective approach to enhancing lung cancer cell sensitivity to IR treatment. The gene discussed is DDIT4; the disease is lung carcinoma.